Key result
DiamondTemp RF ablation combined with EnSite X mapping achieves 100% acute pulmonary vein isolation.
Why the study?
The study was conducted to assess the feasibility of performing AF ablation using the new DiamondTemp RFA catheter in conjunction with the novel EnSite X mapping system under routine clinical conditions.
Is the use of the DiamondTemp RFA catheter guided by the EnSite X mapping system feasible and safe for atrial fibrillation ablation?
Observational (n=10)
No
Is the use of the DiamondTemp RFA catheter guided by the EnSite X mapping system feasible and safe for atrial fibrillation ablation?
Initial clinical experience suggests that using the DiamondTemp RFA catheter with the EnSite X mapping system for AF ablation is feasible, efficient, and safe.
BACKGROUND: The DiamondTemp (DT) radiofrequency ablation (RFA) catheter has been introduced as a new tool for atrial fibrillation (AF) ablation. The new technology allows for temperature-controlled irrigated ablation and real-time lesion assessment. Recently, the EnSite X mapping system became commercially available allowing for omnipolar and ultra-high-resolution mapping. We aimed to assess the feasibility of the new DT RFA catheter in performing AF ablation procedures in conjunction with the novel EnSite X system under routine clinical conditions. METHODS: We analyzed data from 10 consecutive patients who underwent AF ablation using the DT RFA catheter guided by EnSite X. Procedural data and short-term follow-up were assessed as well as potential technical issues. RESULTS: Nine out of 10 patients underwent de-novo pulmonary vein isolation (PVI), and 1 patient underwent repeat ablation. First-pass isolation was observed in 7/10 patients. Total procedure duration (skin-to-skin) was 88.9 ± 30.1 min, and left atrium dwell time was 70 ± 22.3 min. The mean number of RF applications needed for PVI and additional ablation was 70.52 ± 26.70. The HD Grid SE mapping catheter was utilized in 8 patients and the Advisor SE in 2 patients. Bidirectional block of the applied lines was achieved in all patients. No steam pops were observed, and no intraprocedural complications occurred. CONCLUSIONS: This first clinical series demonstrated that temperature-controlled irrigated ablation in combination with the novel omnipolar and high-resolution mapping system resulted in rapid, efficient, and durable lesion formation under routine clinical conditions. Randomized controlled trials are needed to elucidate the impact on lesion formation, long-term outcomes, and reproducibility of our initial findings.
No takes yet. Share an insight, caveat, or question.
Sohns et al. (2023) conducted an observational in Atrial fibrillation (n=10). DiamondTemp radiofrequency ablation catheter with EnSite X mapping system was evaluated on Acute pulmonary vein isolation. The DiamondTemp radiofrequency ablation catheter combined with the EnSite X mapping system achieved acute pulmonary vein isolation in 100% of patients with a mean procedure time of 88.9 minutes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: